Fewer French smokers buy nicotine replacements
This article was originally published in Scrip
French sales of nicotine replacement therapies (NRT) – measured by patient-months of treatment – declined steeply in 2008, even though a law prohibiting smoking in bars and restaurants became effective in the country on January 1st last year. Overall NRT sales were 22.6% lower in 2008.
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.